We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





MEDICA 2023 + COMPAMED 2023 Show the Way Forward in Healthcare

By LabMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: MEDICA 2023 + COMPAMED 2023 have commenced with an increase in bookings and top international participation (Photo courtesy of MEDICA)
Image: MEDICA 2023 + COMPAMED 2023 have commenced with an increase in bookings and top international participation (Photo courtesy of MEDICA)

An audience of medical professionals from across the world and all areas of the healthcare economy is coming together once again in Düsseldorf, Germany as the internationally leading medical trade fair MEDICA (Düsseldorf, Germany) kicks off on November 13 to 16, 2023, with an unprecedented number of participants including over 5,300 companies from close to 70 countries. COMPAMED, which is held in parallel, is the international leading trade fair for suppliers within the medical technology industry, where about 730 companies from 39 countries are participating. After German companies, the largest bookings of floor space has been from China, Italy, Turkey, South Korea, the USA and other European nations such as France, Spain, the United Kingdom and Poland. At COMPAMED, the USA, Italy and Switzerland are at the top behind Germany.

In the halls of the trade fair grounds, exhibitors are presenting a comprehensive range of medical products, devices and instruments for outpatient and clinical treatment which covers all phases of development, production and marketing. MEDICA determines its focus areas in its five worlds of experience covering the huge range of over 10,000 company innovations related to lab technology and diagnostics, medical technology and electromedicine, commodities and consumables, physiotherapy and orthopedic technology as well as IT systems and IT solutions. The highlights of each MEDICA, in addition to the numerous innovations, traditionally also include multi-faceted accompanying programs with celebrity visits and presentations. Moreover, the keynote speakers are expected to particularly spice up the specialist topics.

The on-stage program of the accompanying conferences and the professional forums integrated into the worlds of experience is offering several other highlights. These include the finals of two start-up competitions on the stage of the MEDICA CONNECTED HEALTHCARE FORUM (Hall 12). At the 12th MEDICA Start-up COMPETITION on Tuesday afternoon (14 November), the focus is on the entire spectrum of innovations for the healthcare sector: from artificial intelligence (AI) to health apps, solutions for laboratory diagnostics and medical robotics. For the first time this year, “sustainability” features as a novel category. The 15th “Healthcare Innovation Worldcup” on Monday afternoon (13 November), by contrast, focuses on intelligent “Internet of Medical Things” (IoMT) solutions such as digital biomarkers, smart bandages and network-connectible wearables.

A key trend currently shaping the market is the growing trend of “outpatientisation”. This puts the focus on “point-of-care” products and services that includes patient-oriented diagnostics and treatment, as well as telemedical applications for optimal, cross-sector networking among all those involved in the care process. Other current key trends are procedures based on artificial intelligence (AI) and supporting systems, such as robotic systems or VR/AR (virtual reality/augmented reality) applications, as well as solutions for the implementation of more sustainable processes along the supply and added value chain.

At COMPAMED 2023 in the trade fair Halls 8a and 8b, medical technology industry suppliers are showing what they are capable of. The exhibiting companies are also presenting (five) worlds of experience including a wide range of high-tech and service solutions. The five worlds of experience are: Manufacturing & Devices (e.g., components, parts, manufacturing processes), Services & Advice (e.g., research, development, services), Materials (e.g., plastics, glass, ceramics, metals, composite materials, adhesives, packaging), Micro Tech (such as micro components, microfluidics) as well as IT in Tech (software development and maintenance for medical technology). The program sessions, the COMPAMED HIGH-TECH FORUM and the COMPAMED SUPPLIERS FORUM will be following important industry and technological trends and provide practical information related to new procedures, products and relevant aspects of work on international markets.

Related Links:
MEDICA

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Coagulation Analyzer
CS-2400
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.